Invesaro

Stocks Finance TDAC

NASDAQ · Finance

Translational Development Acquisition Corp. (TDAC)

At June 30, 2026 it held $85.9K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

What Translational Development Acquisition Corp. does

Translational Development Acquisition Corp. is registered with the SEC under industry code SIC 6770 (Blank Checks). Its shares trade on NASDAQ under the ticker TDAC.

Revenue and profit by year

Net income
FY24: -$485.6K -$485.6K FY24FY24: -$71K -$71K FY24FY25: $6.4M $6.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$944.5K$6.4Mn/an/a
2024n/a-$196.4K-$71Kn/an/a
2024n/a-$485.6K-$485.6Kn/an/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 14, 2025. Not a date the company has announced. See the report calendar

Latest SEC filings

What Translational Development Acquisition Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Net income fell 42% to $947K.
  2. August 14, 2026
  3. August 14, 2026
  4. August 12, 2026
  5. July 27, 2026
  6. July 27, 2026
  7. July 16, 2026
  8. July 8, 2026
  9. June 23, 2026
  10. June 23, 2026

Recent insider filings (Forms 3, 4 and 144): 8, the latest on May 29, 2026. Insider transactions on SEC

Insider trades

What the people running Translational Development Acquisition Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns TDAC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Linden Advisors LP13G, passive with 3 related filers 6.7% 1,150,000 August 14, 2026
Meteora Capital, LLC13G, passive 6.27% 919,000 August 14, 2026

Latest filings below 5%: Wolverine Asset Management, LLC 4.89% (July 16, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about TDAC

What does Translational Development Acquisition Corp. do?

Translational Development Acquisition Corp. is registered with the SEC under industry code SIC 6770 (Blank Checks). Its shares trade on NASDAQ under the ticker TDAC.

Is Translational Development Acquisition Corp. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $5.5M.

When did Translational Development Acquisition Corp. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.

Similar companies

Compare TDAC with

Compare TDAC with any company

Follow TDAC

Get an email when Translational Development Acquisition Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow TDAC: get an email when it files

Where the numbers come from

Financial figures are the values Translational Development Acquisition Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.